• Info
  • Insider Ownership

Insider Trading & Ownership of Royalty Pharma Investments 2019 ICAV

Location
New York, NY
Summary
The estimated net worth of Royalty Pharma Investments 2019 ICAV is at least $31,960,000 dollars as of 09 Feb 2022. Royalty Pharma Investments 2019 ICAV is the Director, 10%+ Owner of Epizyme, Inc. and owns shares of Epizyme, Inc. stock worth about $31.96M.
Signature
Royalty Pharma Investments 2019 ICAV, By: /s/ Pablo G. Legorreta, Director
All Insider Reports
All Insider Reports

Notify me when Royalty Pharma Investments 2019 ICAV files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Royalty Pharma Investments 2019 ICAV

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
EPZM Epizyme, Inc. Director, 10%+ Owner $31,960,000 31 Jan 2022

There are no insider transactions reported by Royalty Pharma Investments 2019 ICAV